Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
FDA Draft Guidance on Multiregional Clinical Development Programs for Oncology
Blog Posts
WCG Clinical | Insights
Q&A: Framework for AI Adoption in Clinical Trials
Blog Posts
WCG Clinical | Insights
Navigating the Maze of Endpoint Adjudication Committees: Why Naming Conventions Matter for Your Clinical Trial
Blog Posts
WCG Clinical | Insights
Technology Focus: The Use of AI in Consent Form Development
Blog Posts
WCG Clinical | Insights
Elevate Training to Overcome Site Burden and Reduce Protocol Deviations by 35-50%
Blog Posts
WCG Clinical | Insights
The FDA’s Updated IRB Bioresearch Monitoring (BIMO) Inspection Manual
Blog Posts
WCG Clinical | Insights
Protocol Deviations Explained: Understanding the FDA’s Draft Guidance
Blog Posts
WCG Clinical | Insights
Celebrating 25 Years of IBC Reviews: Pioneering the Past, Shaping the Future
Blog Posts
WCG Clinical | Insights
Best Practices for Protecting Non-Participants in Human Gene Transfer Clinical Trials
Blog Posts
WCG Clinical | Insights